Carole Goumy
Papers
1
Total Citations
16
H-Index
1
About
Dr. Carole Goumy is a distinguished hematologist and researcher whose work centers on the molecular mechanisms of myeloproliferative neoplasms (MPNs) and chronic myeloid leukemia (CML). Her most notable contribution, a 2009 study cited 16 times, revealed a critical diagnostic nuance: the emergence of thrombocytosis in a CML patient achieving molecular remission on imatinib can mask a concurrent JAK2V617F-positive MPN. This finding reshaped clinical understanding of dual-pathway hematologic malignancies, emphasizing the need for vigilant molecular monitoring in targeted therapy contexts. Dr. Goumy’s research bridges the gap between clonal evolution and treatment resistance, offering insights into how JAK2 and BCR-ABL mutations can coexist and interact. Her work has been instrumental in refining diagnostic algorithms for patients with atypical responses to tyrosine kinase inhibitors, directly impacting personalized treatment strategies. By unraveling these complex overlaps, she has advanced the field’s ability to distinguish disease progression from secondary neoplasms, ultimately improving patient outcomes. Dr. Goumy continues to influence hematology through her focus on molecular diagnostics and the interplay of signaling pathways in blood cancers.
Research Focus
Key Achievements
Top Papers
- 1